Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP882033.RArYI6swgBXcwaK9Agp582n3VxglbNFrL20_T4nG5Su4k130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP882033.RArYI6swgBXcwaK9Agp582n3VxglbNFrL20_T4nG5Su4k130_assertion type Assertion NP882033.RArYI6swgBXcwaK9Agp582n3VxglbNFrL20_T4nG5Su4k130_head.
- NP882033.RArYI6swgBXcwaK9Agp582n3VxglbNFrL20_T4nG5Su4k130_assertion description "[In addition, the levels of the E7 oncoprotein were at least as high as in cancer derived cell lines, suggesting that E2 interruption, observed in cancer derived cell lines, is not causally related to the high level of E7 expression and, therefore, deregulation of the P97 promoter may not be a prerequisite for HPV-16 associated cancer development.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP882033.RArYI6swgBXcwaK9Agp582n3VxglbNFrL20_T4nG5Su4k130_provenance.
- NP882033.RArYI6swgBXcwaK9Agp582n3VxglbNFrL20_T4nG5Su4k130_assertion evidence source_evidence_literature NP882033.RArYI6swgBXcwaK9Agp582n3VxglbNFrL20_T4nG5Su4k130_provenance.
- NP882033.RArYI6swgBXcwaK9Agp582n3VxglbNFrL20_T4nG5Su4k130_assertion SIO_000772 1651587 NP882033.RArYI6swgBXcwaK9Agp582n3VxglbNFrL20_T4nG5Su4k130_provenance.
- NP882033.RArYI6swgBXcwaK9Agp582n3VxglbNFrL20_T4nG5Su4k130_assertion wasDerivedFrom befree-20140225 NP882033.RArYI6swgBXcwaK9Agp582n3VxglbNFrL20_T4nG5Su4k130_provenance.
- NP882033.RArYI6swgBXcwaK9Agp582n3VxglbNFrL20_T4nG5Su4k130_assertion wasGeneratedBy ECO_0000203 NP882033.RArYI6swgBXcwaK9Agp582n3VxglbNFrL20_T4nG5Su4k130_provenance.